Abstract:Cellular senescence is a permanent state of cell cycle arrest characterized by increased activity of senescence associated β-galactosidase (SA-β-gal). Notably, cancer cells have been also observed to exhibit the senescence response and are being considered for sequential treatment with pro-senescence therapy followed by senolytic therapy. However, there is currently no effective agent targeting β-galactosidase (β-Gal) for imaging cellular senescence and monitoring senolysis in cancer therapy. Aggregation-induced emission luminogen (AIEgen) demonstrates strong fluorescence, good photostability, and biocompatibility, making it a potential candidate for imaging cellular senescence and monitoring senolysis in cancer therapy when endowed with β-Gal-responsive capabilities. In this study, we introduced a β-Gal-activated AIEgen named QM-β-gal for cellular senescence imaging and senolysis monitoring in cancer therapy. QM-β-gal exhibited good amphiphilic properties and formed aggregates that emitted a fluorescence signal upon β-Gal activation. It showed high specificity towards the activity of β-Gal in lysosomes and successfully visualized DOX-induced senescent cancer cells with intense fluorescence both in vitro and in vivo. Encouragingly, QM-β-gal could image senescent cancer cells in vivo for over 14 days with excellent biocompatibility. Moreover, it allowed for the monitoring of senescent cancer cell clearance during senolytic therapy with ABT263. This investigation indicated the potential of the β-Gal-activated AIEgen, QM-β-gal, as an in vivo approach for imaging cellular senescence and monitoring senolysis in cancer therapy via highly specific and long-term fluorescence imaging. STATEMENT OF SIGNIFICANCE: This work reported a β-galactosidase-activated AIEgen called QM-β-gal, which effectively imaged DOX-induced senescent cancer cells both in vitro and in vivo. QM-β-gal specifically targeted the increased expression and activity of β-galactosidase in senescent cancer cells, localized within lysosomes. It was cleared rapidly before activation but maintained stability after activation in the DOX-induced senescent tumor. The AIEgen exhibited a remarkable long-term imaging capability for senescent cancer cells, lasting over 14 days and enabled monitoring of senescent cancer cell clearance through ABT263-induced apoptosis. This approach held promise for researchers seeking to achieve prolonged imaging of senescent cells in vivo.

Indocyanine Green‐based Nanoprobe for In Vivo Detection of Cellular Senescence

A Near-Infrared Triggered Multi-Functional Indocyanine Green Nanocomposite with NO Gas Release Function Inducing Improved Photothermal Therapy

Aptamer Conjugate-Based Ratiometric Fluorescent Probe for Precise Imaging of Therapy-Induced Cancer Senescence.

Noninvasive NIR Imaging of Senescence via In Situ Labeling

An Activatable NIR Probe for the Detection and Elimination of Senescent Cells

A rationally designed fluorescence probe achieves highly specific and long‐term detection of senescence in vitro and in vivo

Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence.

Dual-Parameter Recognition-Directed Design of the Activatable Fluorescence Probe for Precise Imaging of Cellular Senescence.

Activatable Multiplexed 19F NMR Probes for Dynamic Monitoring of Biomarkers Associated with Cellular Senescence

A Near-Infrared Fluorescent Probe for Fast and Precise Imaging of Senescent Cells and Ovarian Cancer Cells Via Tracking Β-Galactosidase

Biodegradable Nanoprobe for NIR‐II Fluorescence Image‐Guided Surgery and Enhanced Breast Cancer Radiotherapy Efficacy

Novel PET Imaging Probe for Quantitative Detection of Senescence In Vivo

<i>In Vivo</i> Imaging of Senescent Vascular Cells in Atherosclerotic Mice Using a -Galactosidase-Activatable Nanoprobe

Β-Galactosidase-activatable Fluorescent and Photoacoustic Imaging of Tumor Senescence.

Cellular senescence in cancer: from mechanisms to detection

Cellular senescence imaging and senolysis monitoring in cancer therapy based on a β-galactosidase-activated aggregation-induced emission luminogen

Kill Two Birds with One Stone: A Near-Infrared Ratiometric Fluorescent Probe for Simultaneous Detection of Β-Galactosidase in Senescent and Cancer Cells

Recent Developments in Small-Molecule Fluorescent Probes for Cellular Senescence

Ratiometric Fluorescent Probe for Real-Time Detection of β-Galactosidase Activity in Lysosomes and Its Application in Drug-Induced Senescence Imaging

A near-infrared fluorescent nanoprobe for senescence-associated β-galactosidase sensing in living cells

Injectable and Sprayable Fluorescent Nanoprobe for Rapid Real‐Time Detection of Human Colorectal Tumors